Revolution Medicines, Inc.
Revolution Medicines, Inc. (RVMD) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
rvmd · stock forecast · 22 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 22 Wall Street analysts in the past 3 months
Buy
22 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$205
Consensus
$165
+11.1% upside
Low
$73.00
Median: $174.5 · Last Close: $148.84
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$165.33
11.1% upside
High Target
$205
37.7%
Low Target
$73
-51.0%
Current Price
$148.84
as of today
Based on analyst price targets, the RVMD stock price prediction for the next 12 months ranges from $73 to $205. The consensus RVMD price forecast of $165.33 implies 11.1% upside from the current price of $148.84.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $149.35 | ↑ 0.35% |
1-day model range: $148.41–$150.3. Peak: $150.3 (+0.35%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RVMD · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-06-01 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-06-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-07 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-07 | Needham | Maintains | Buy→Buy |
| 2026-05-07 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-05-07 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-07 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-22 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-04-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Revolution Medicines, Inc. (RVMD) stock. Of the recent 136 rating actions, 4 were upgrades and 1 were downgrades. 22 analysts currently cover RVMD.
Analyst Recommendation Trends
RVMD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$100M
↓ 94.6% YoY
Revenue Next Year
$819M
↑ 718.6% YoY
EPS This Year
$-7.96
EPS Next Year
$-5.65
↓ 29.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast RVMD EPS of $-7.96 for the current fiscal year, based on estimates from 17 analysts. The RVMD revenue forecast is $100M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The RVMD stock forecast is supported by two independent data sources: analyst consensus ratings from 22 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus RVMD price target is $165.33 (+11.1% upside), with an analyst consensus of Buy.
The RVMD short-term stock prediction for tomorrow is $149.35 (+0.35%).
Revolution Medicines, Inc. trades on NASDAQ under the ticker RVMD. The RVMD stock outlook for 2027 is broadly positive, supported by a Buy consensus among 95% of covering analysts.
Frequently asked questions
RVMD forecast · 8 questionsAccording to 22 Wall Street analysts, the average 12-month RVMD price target is $165.33, with a high forecast of $205.00 and a low of $73.00. The median price target is shown in the chart above when available. This implies +11.1% potential upside from the current price of $148.84.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.